SWOG
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 1956-01-01
- Employees
- 101
- Market Cap
- -
- Website
- http://www.swog.org
S9715, Chemotherapy and Radiation Therapy in Treating Patients With Advanced Cancer of the Nasopharynx
- Conditions
- Head and Neck Cancer
- First Posted Date
- 2004-07-05
- Last Posted Date
- 2015-05-27
- Lead Sponsor
- SWOG Cancer Research Network
- Registration Number
- NCT00002999
SWOG-9416: Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Stage III Non-small Cell Lung Cancer
- Conditions
- Lung Cancer
- Interventions
- Procedure: conventional surgeryRadiation: low-LET cobalt-60 gamma ray therapy
- First Posted Date
- 2004-06-30
- Last Posted Date
- 2012-10-08
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 116
- Registration Number
- NCT00002642
- Locations
- 🇺🇸
Vanderbilt Cancer Center, Nashville, Tennessee, United States
S9626: Megestrol in Treating Hot Flashes Following Treatment for Breast Cancer
- Conditions
- Breast CancerHot Flashes
- Interventions
- First Posted Date
- 2004-06-28
- Last Posted Date
- 2015-11-18
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 288
- Registration Number
- NCT00005975
S9717 Tirapazamine Plus Cisplatin in Treating Patients With Metastatic, Recurrent, or Refractory Cervical Cancer
- First Posted Date
- 2004-06-24
- Last Posted Date
- 2012-06-14
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 56
- Registration Number
- NCT00003369
- Locations
- 🇺🇸
University of Mississippi Medical Center, Jackson, Mississippi, United States
🇺🇸Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States
🇺🇸CCOP - Atlanta Regional, Atlanta, Georgia, United States
S9720 Combination Chemotherapy in Treating Patients With Metastatic, Recurrent, or Refractory Endometrial Cancer
- Conditions
- Endometrial Cancer
- Interventions
- First Posted Date
- 2004-06-24
- Last Posted Date
- 2012-06-14
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 57
- Registration Number
- NCT00003127
- Locations
- 🇺🇸
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States
🇺🇸CCOP - Atlanta Regional, Atlanta, Georgia, United States
🇺🇸Providence Hospital - Southfield, Southfield, Michigan, United States
S9716: Combination Chemotherapy in Treating Patients With Merkel Cell Cancer
- Conditions
- Neuroendocrine Carcinoma of the Skin
- First Posted Date
- 2004-06-24
- Last Posted Date
- 2012-10-08
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 80
- Registration Number
- NCT00003549
- Locations
- 🇺🇸
USC/Norris Comprehensive Cancer Center, Los Angeles, California, United States
🇺🇸Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States
🇺🇸Veterans Affairs Outpatient Clinic - Martinez, Martinez, California, United States
S9810: Gemcitabine Plus Cisplatin in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot Be Removed by Surgery
- First Posted Date
- 2004-06-24
- Last Posted Date
- 2012-10-08
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 57
- Registration Number
- NCT00003723
- Locations
- 🇺🇸
Beckman Research Institute, City of Hope, Los Angeles, California, United States
🇺🇸Veterans Affairs Outpatient Clinic - Martinez, Martinez, California, United States
🇺🇸Providence Hospital - Southfield, Southfield, Michigan, United States
SWOG-9239 Reduction of Immunosuppression Plus Interferon Alfa and Combination Chemotherapy in Treating Patients With Malignant Tumors That Develop After Organ Transplant
- Conditions
- LymphomaMultiple Myeloma and Plasma Cell Neoplasm
- Interventions
- Biological: bleomycin sulfateBiological: recombinant interferon alfaProcedure: conventional surgeryRadiation: radiation therapy
- First Posted Date
- 2004-06-22
- Last Posted Date
- 2013-01-24
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 20
- Registration Number
- NCT00002657
- Locations
- 🇺🇸
Providence Hospital - Southfield, Southfield, Michigan, United States
🇺🇸CCOP - Dayton, Kettering, Ohio, United States
🇺🇸Boston Medical Center, Boston, Massachusetts, United States
S9918 PSC 833, Daunorubicin, and Cytarabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia
- Conditions
- Leukemia
- First Posted Date
- 2004-06-18
- Last Posted Date
- 2015-03-06
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 55
- Registration Number
- NCT00004217
- Locations
- 🇺🇸
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States
🇺🇸Veterans Affairs Outpatient Clinic - Martinez, Martinez, California, United States
🇺🇸University of Texas Medical Branch, Galveston, Texas, United States
S0106 Cytarabine and Daunorubicin w/ or w/o Gemtuzumab Followed By HD Cytarabine and Either Gemtuzumab or Nothing in de Novo AML
- Conditions
- Leukemia
- Interventions
- First Posted Date
- 2004-06-16
- Last Posted Date
- 2015-09-30
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 637
- Registration Number
- NCT00085709
- Locations
- 🇺🇸
Perry Memorial Hospital, Princeton, Illinois, United States
🇺🇸Cancer Center of Kansas-Independence, Independence, Kansas, United States
🇺🇸Munson Medical Center, Traverse City, Michigan, United States